Company data
Nuvation Bio Inc. employees and revenue per employee
NUVB · Biotechnology · $1.34B market cap
Nuvation Bio Inc. had 298 employees at the end of fiscal Dec 2025, up 35.5% from a year earlier. Revenue for the year was $62.9M, up 699.0% from a year earlier, or $211K per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
298
+35.5% YoY
Revenue
$62.9M
+699.0% YoY
Revenue / employee
$211K
Peer median $457K
Rank in industry
79 of 110
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 298 | $62.9M | $211K | +35.5% | +699.0% |
| Dec 2024 | 220 | $7.9M | $36K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Nuvation Bio Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| NKTR Nektar Therapeutics | 63 | $55.2M | $877K | Hiring into decline |
| ENTA Enanta Pharmaceuticals, Inc. | 74 | $63.0M | $851K | Contracting |
| ARCT Arcturus Therapeutics Holdings Inc. | 106 | $67.2M | $634K | Contracting |
| TNGX Tango Therapeutics, Inc. | 137 | $62.4M | $455K | Leaner |
| VRDN Viridian Therapeutics, Inc. | 252 | $70.8M | $281K | Efficient growth |
| KURA Kura Oncology, Inc. | 260 | $67.5M | $260K | Hiring ahead |
| NUVB Nuvation Bio Inc. | 298 | $62.9M | $211K | Efficient growth |
| VIR Vir Biotechnology, Inc. | 367 | $68.6M | $187K | Contracting |
| NTLA Intellia Therapeutics, Inc. | 377 | $67.7M | $179K | Leaner |
Questions about Nuvation Bio Inc.
- How many employees does Nuvation Bio Inc. have?
- Nuvation Bio Inc. reported 298 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 2, 2026. That is up 35.5% from a year earlier.
- What is Nuvation Bio Inc.'s revenue per employee?
- Nuvation Bio Inc. brought in $62.9M of revenue in fiscal Dec 2025, which is $211K per employee. That ranks 79 of 110 companies we track in Biotechnology, where the median is $457K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Outpick research
This page is the filings. The research is a membership.
On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare NUVB with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Nuvation Bio Inc.'s annual reports (Form 10-K), latest filed March 2, 2026. This is data, not a recommendation to buy or sell NUVB.